Your fact-checks will appear here
Biopharmaceutical company
Neurocept has no clearly documented, completed clinical trials for depression through 2023 in the provided dataset; available records instead point to a ClinicalTrials.gov entry for a study of NMRA‑33...
Neurocept’s public record in the provided materials is : some documents describe a commercial brain-health supplement named “Neurocept” or “NeuroCept” and a “Pg Capsule” formulation with therapeutic c...
Neurocept does not have clear, widely reported completed clinical trials for major depressive disorder (MDD) through the end of 2023; the only firm item tied to the company in the provided material is...